Project Grant R03NS139043

Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $165K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $147,507 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to the University of California, Davis. The project, titled "The Encoding of Proprioceptive Signaling by NAV1.6", aims to uncover the mechanistic role of the sodium channel NAV1.6 in proprioceptive signaling, which is critical for sensory-driven motor behaviors. The research will...
This federal Project Grant award of $458,806 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will support research at the University of Chicago to characterize the fundamental differences between projection and local pathways of proprioceptive signaling in Drosophila larvae. The research aims to provide a comprehensive anatomical...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research program aims to advance the understanding of muscle spindle function and its role in human sensorimotor control of balance and movement. The $224,580 award, spanning August 2025 to July 2027, will fund a research project at Emory University that combines computational modeling, microneurography...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,830,562 to President And Fellows Of Harvard College, doing business as Harvard Medical School, from September 1, 2024 to May 8, 2025. The award supports research to elucidate the properties and functions of different types of mechanosensory neurons, define the organizational...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding the generation and characterization of a novel NTRK3-FLPO knockin mouse line at the University of Pennsylvania. The goal is to enable specific genetic targeting and interrogation of A-beta nociceptors, an important but understudied subpopulation of somatosensory neurons, in order...
This five-year, $649,659 National Science Foundation Engineering Project Grant will support research at the Massachusetts Institute of Technology to advance fundamental understanding of the tissues that produce voluntary movement in humans and other biological creatures. Specifically, the grant will fund experiments studying how mechanical signaling coordinates assembly, maturation and repair at the neuromuscular interface in both physiological and pathological states. The principal investigator...
This Project Grant award from the National Institute on Aging (NIA) under CFDA 93.866 (Aging Research) provides $1,130,661.00 to the Regents of the University of Michigan to conduct research on the cellular and molecular mechanisms underlying motor unit expansion, a compensatory process that preserves muscle function during aging and neurodegenerative conditions like amyotrophic lateral sclerosis (ALS). The project aims to: (I) characterize how Schwann cell populations and their signaling...
This Project Grant award, valued at $359,133.00, was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports the generation of new genetic tools to enable more targeted and specific analysis of tendon and musculoskeletal tissues in mice. The goal is to develop constitutive and inducible FLP alleles that can be used in combination with existing...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $462,296 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the University of Louisville to conduct research on propriospinal plasticity and recovery after incomplete spinal cord injury. The project aims to investigate the anatomical plasticity exhibited by long-ascending propriospinal neurons (LAPNs) following spinal cord injury, the impact of silencing...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $291,284 to Drexel University to investigate the role of medial laminae V/VI glycinergic interneurons in locomotor recovery following spinal cord injury. The research aims to identify this specific inhibitory interneuron population and understand how disruption of proprioceptive...

DEVELOPING GENETIC ACCESS TO GROUP II PROPRIOCEPTIVE MUSCLE AFFERENTS - SUMMARY THE PROPRIOCEPTIVE SENSE LARGELY DERIVES FROM TWO SPECIALIZED RECEPTOR ORGANS IN SKELETAL MUSCLE: MUSCLE SPINDLES (MSS) AND GOLGI TENDON ORGANS (GTOS). THE AFFERENTS ASSOCIATED WITH THESE SENSORY END ORGANS ARE GROUPS IA AND II MS-AFFERENTS AND GROUP IB GTO AFFERENTS, WHICH RELAY INFORMATION ABOUT LIMB MOVEMENT AND POSITION (MS), OR MUSCLE LOAD (GTO) FROM THE PERIPHERAL RECEPTORS TO THE SPINAL CORD AND BRAINSTEM. MS AFFERENTS ARE THE PRIMARY KINESTHETIC SENSORS THAT ENHANCE THEIR FIRING RATES WITH INCREASES IN MUSCLE LENGTH, WHICH IN TURN SERVES AS AN INDIRECT READOUT OF JOINT POSITION. WHILE MS GROUP IA AFFERENT CAN RELAY DYNAMIC CHANGES, MS GROUP II AFFERENTS ARE, ON AVERAGE, MORE SENSITIVE FOR STATIC STRETCH WHEN COMPARED TO GROUP IA AFFERENTS AND ARE FAR MORE NUMEROUS. THESE OBSERVATIONS HAVE LED TO THE IDEA THAT GROUP II AFFERENTS ARE THE MAIN MEDIATORS OF LIMB AND BODY POSITION SENSE. GROUP II AFFERENTS THEREFORE NOT ONLY PLAY A KEY ROLE IN VARIOUS MOTOR FUNCTIONS, BUT ALSO ARE CENTRAL TO THE SENSE OF SELF AND AGENCY, THE SENSE OF BEING IN CONTROL OF ONE'S ACTIONS. DESPITE THEIR IMPORTANCE, SYSTEMATIC ANALYSES OF GROUP II FUNCTION OR THEIR DOWNSTREAM NEURAL CIRCUITS REMAINS SCARCE. HISTORICALLY, A KEY DIFFICULTY IN STUDYING GROUP II AFFERENTS HAS BEEN THE INABILITY TO CLEARLY DISTINGUISH THEM FROM MS GROUP IA AFFERENTS THROUGH PHYSIOLOGICAL OR GENETIC MEANS. MOST STIMULI THAT ACTIVATE GROUP II'S WILL ALSO ACTIVATE GROUP IA'S AND GENETIC REPORTERS FOR INDIVIDUAL PROPRIOCEPTOR SUBTYPES WERE NOT YET IDENTIFIED. IN RECENT YEARS, HOWEVER, MY LAB IDENTIFIED EXPRESSION OF NEUREXOPHILIN 1 (NXPH1), A MEMBER OF THE NEUREXOPHILIN FAMILY OF SECRETED GLYCOPROTEINS AS A UNIVERSAL MARKER FOR MS GROUP II AFFERENTS. ADDITIONAL EXPRESSION ANALYSES INDICATE THAT THE NXPH1 LOCUS OFFERS A UNIQUE OPPORTUNITY TO STUDY THE DEVELOPMENT, CIRCUITRY AND FUNCTION OF MOUSE GROUP II PROPRIOCEPTIVE MUSCLE AFFERENTS. TOWARDS THIS GOAL, THIS PROPOSAL WILL DEVELOP AND VALIDATE A NOVEL NXPH1:CRE ANIMAL MODEL TO ENABLE THE SELECTIVE MANIPULATION OF ADULT GROUP II MUSCLE SPINDLE AFFERENTS. THESE EXPERIMENTS WILL PROVIDE THE RESEARCH COMMUNITY WITH A NEW GENETIC MOUSE MODEL THAT WILL BE ESSENTIAL FOR THE STUDY OF GROUP II MUSCLE AFFERENTS IN HEALTH AND DISEASE.

Posted 6/12/24